Somerset Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Somerset Group's GILD Position: Q4 2017 in Review
Somerset Group sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 2,965 shares — an estimated $240K sold.
Somerset Group first reported a position in GILD in Q3 2013 and held it in 17 quarters. The position peaked at $719K in Q3 2014. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.
- Somerset Group reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
- Somerset Group sold 2,965 Gilead Sciences shares in Q4 2017, an estimated $240K.
- Somerset Group first reported a position in Gilead Sciences in Q3 2013 and held it in 17 quarters.
- Somerset Group's Gilead Sciences position peaked at $719K in Q3 2014.
- 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.
Based on Somerset Group's 13F filing for Q4 2017, filed 12 Feb 2018.